Transgenic mice expressing yellow fluorescent protein under control of the human tyrosine hydroxylase promoter

2012 ◽  
Vol 90 (10) ◽  
pp. 1949-1959 ◽  
Author(s):  
Eun Yang Choi ◽  
Jae Won Yang ◽  
Myung Sun Park ◽  
Woong Sun ◽  
Hyun Kim ◽  
...  
1992 ◽  
Vol 16 (3-4) ◽  
pp. 274-286 ◽  
Author(s):  
Toshikuni Sasaoka ◽  
Kazuto Kobayashi ◽  
Ikuko Nagatsu ◽  
Riichi Takahashi ◽  
Minoru Kimura ◽  
...  

1998 ◽  
Vol 18 (23) ◽  
pp. 9989-9995 ◽  
Author(s):  
Virginia A. Boundy ◽  
Stephen J. Gold ◽  
Chad J. Messer ◽  
Jingshan Chen ◽  
Jin H. Son ◽  
...  

2001 ◽  
Vol 8 (3) ◽  
pp. 535-539 ◽  
Author(s):  
Yasuji Matsuoka ◽  
Miquel Vila ◽  
Sarah Lincoln ◽  
Alison McCormack ◽  
Melanie Picciano ◽  
...  

2019 ◽  
pp. 525-530
Author(s):  
N. Lipták ◽  
Z. Bősze ◽  
L. Hiripi

Green Fluorescent protein (GFP) transgenic animals are accepted tools for studying various physiological processes, including organ development and cell migration. However, several in vivo studies claimed that GFP may impair transgenic animals’ health. Glomerulosclerosis was observed in transgenic mice and rabbits with ubiquitous reporter protein expression. Heart-specific GFP expression evoked dilated cardiomyopathy and altered cardiac function in transgenic mouse and zebrafish lines, respectively. Moreover, growth retardation and increased axon swelling were observed in GFP and yellow fluorescent protein (YFP) transgenic mice, respectively. This review will focus on the potential drawbacks of the applications of GFP transgenic animals in biomedical research.


Cureus ◽  
2011 ◽  
Author(s):  
Kenneth W. Dodd ◽  
Terry C. Burns ◽  
Stephen M. Weisner ◽  
Elina Kudishevich ◽  
Dominic T. Schomberg ◽  
...  

2002 ◽  
Vol 15 (1) ◽  
pp. 40-50 ◽  
Author(s):  
Friedrich Metzger ◽  
Vez Repunte-Canonigo ◽  
Shinichi Matsushita ◽  
Walther Akemann ◽  
Javier Diez-Garcia ◽  
...  

PLoS ONE ◽  
2011 ◽  
Vol 6 (3) ◽  
pp. e17639 ◽  
Author(s):  
Laura H. Comley ◽  
Thomas M. Wishart ◽  
Becki Baxter ◽  
Lyndsay M. Murray ◽  
Ailish Nimmo ◽  
...  

2003 ◽  
Vol 285 (1) ◽  
pp. F33-F39 ◽  
Author(s):  
Peter K. Stricklett ◽  
Deborah Taylor ◽  
Raoul D. Nelson ◽  
Donald E. Kohan

Evaluation of thick ascending limb (TAL) function has been hindered by the limited ability to selectively examine the function of this nephron segment in vivo. To address this, a Cre/loxP strategy was employed whereby the Tamm-Horsfall (THP) promoter was used to drive Cre recombinase expression in transgenic mice. The THP gene was cloned from a mouse genomic library, and 3.7 kb of the mouse THP 5′-flanking region containing the first noncoding exon of the THP gene were inserted upstream of an epitope-tagged Cre recombinase (THP-CreTag). THP-CreTag transgenic mice were bred with ROSA26-enhanced yellow fluorescent protein (eYFP) mice (contain a loxP-flanked “STOP” sequence 5′ to eYFP), and doubly heterozygous offspring were analyzed. THP and eYFP were expressed in an identical pattern with predominant localization to the renal outer medulla without expression in nonrenal tissues. eYFP did not colocalize with thiazide-sensitive cotransporter (distal tubule) or neuronal nitric oxide synthase (macula densa) expression. THP mRNA expression was detected only in kidney, whereas CreTag mRNA was also present in testes. These data indicate that THP-CreTag transgenic mice can be used for TAL-specific gene recombination in the kidney.


Sign in / Sign up

Export Citation Format

Share Document